Mediators of injury in lupus nephritis

Current Opinion in Rheumatology

Volumn 14, Issue 5, 2002, Pages 498-503

  Oates, Jim C ^a   Gilkeson, Gary S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; DNA ANTIBODY; DOUBLE STRANDED DNA; FC RECEPTOR; GAMMA INTERFERON; ICOSANOID; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; KININ; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PHOSPHOLIPID ANTIBODY; THROMBOXANE A2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; AUTACOID;

ANIMAL MODEL; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CYTOTOXICITY; GLOMERULONEPHRITIS; HUMAN; INFLAMMATORY CELL; KIDNEY FIBROSIS; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ANTIGEN ANTIBODY COMPLEX; FIBROSIS; IMMUNOLOGY; PATHOLOGY;

ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; FIBROSIS; HUMAN; INFLAMMATION MEDIATORS; LUPUS NEPHRITIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; HUMANS;

EID: 0036707730     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200209000-00003     Document Type: Review

References (71)

1. Lupus nephritis
2. Lupus nephritis
3. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: A case for tissue injury by molecular mimicry
4. Alpha-actinin is a cross-reactive renat target for pathogenic anti-DNA antibodies
5. From T to B and back again: Positive feedback in systemic autoimmune disease
6. The role of B cells in lpr/lpr-induced autoimmunity
7. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice
8. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus
9. Deficiency in β(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL- Fas(lpr) nice: An example of disease regulation at the organ level
10. Cutting edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease
11. Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis
12. Cutting edge: Reversal of murine lupus nephritis with CTLA4lg and cyclophosphamide
13. The Fcγ receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians
14. Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients
15. Fcgamma receptor polymorphisms in systemic lupus erythematosus: Association with disease and in vivo clearance of immune complexes
16. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis
17. Spontaneous autoimmune disease in Fc(γ)RIIB-deficient mice results from strain-specific epistasis
18. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization
19. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice
20. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B
21. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis
22. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis
23. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis
24. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC
25. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus
26. Predominance of Th1 immune response in diffuse proliferative lupus nephritis
27. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane
28. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice
29. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice
30. Evidence for an interferon-inducible gene, lfi202, in the susceptibility to systemic lupus
31. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon
32. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis
33. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice
34. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL:MP-lpr:lpr mice
35. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL- FAS(lprcg)/FAS(lprcg) mice
36. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice
37. Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus
38. Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients
39. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis
40. Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis
41. Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium
42. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells
43. Elevated interleukin-13 in patients with active lupus nephritis
44. Systemic lupus erythematosus and dysregulated apoptosis - What is the evidence?
45. Impaired apoptosis, extended duration of immune responses, and a lupus- like autoimmune disease in IEX-1-transgenic mice
46. Polyclonal anticardiolipin antibodies purified from sera of patients with active systemic lupus erythematosus induce apoptosis of the cultured glomerular mesangial cells
47. Cutting edge: Amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-(beta-o-methyl)-fluoromethylketone
48. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine
49. Effect of late modulation of nitric oxide production on murine lupus
50. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase
51. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists
52. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice
53. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite
54. Nrf2-deficient female mice develop lupus-like autoimmune nephritis
55. Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis
56. Improvement of renal function with selective thromboxane antagonism in lupus nephritis
57. Thromboxane receptor blockade reduces renal injury in murine lupus nephritis
58. Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in lupus nephritis
59. The role of thromboxane A2 in experimental and human models of chronic glomerular damage
60. Thromboxane A(2) causes retarded clearance of aggregated protein in glomeruli of nephritic mice
61. Events that stimulate release of thromboxane B2 in passive heymann nephritis
62. Hyaluronan-induced cyclooxygenase-2 expression promotes thromboxane A2 production by renal cells
63. Angiotensin-converting enzyme gene and diabetes mellitus
64. Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis
65. Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus
66. Kinin system in lupus nephritis
67. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus
68. Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis
69. Anticardiolipin antibodies in South African patients with lupus nephritis: A clinical and renal pathological study
70. Activated intrarenal transcription of CTL-effectors and TGF-β1 in children with focal segmental glomerulosclerosis
71. Expression of transforming growth factor-β and tumor necrosis factor-α in the plasma and tissues of mice with lupus nephritis